Maha Shivratri Offer- Use Code SHIVRATRI24

Register Now

BBIL, Sydney University ink MoU to collaborate on vaccine R&D & infectious diseases

Published on November 30, 2023
Current Context: The Memorandum of Understanding (MoU) between Bharat Biotech International Limited (BBIL) and the University of Sydney Infectious Diseases Institute was announced on Tuesday, November 28, 2023 in Hydrabad to advance vaccine research initiatives.
BBIL, Sydney University ink MoU to collaborate on vaccine R&D & infectious diseases
  • This international agreement aims to build strong sectoral and cross-organizational collaborations to design novel methodologies to tackle future epidemics and infectious diseases.
  • The collaboration will strengthen academic-industry partnerships and augment global efforts to combat infectious diseases.
  • It will leverage academic and industry strengths to advance the science of vaccines and biotherapeutics.
  • Dr. Krishna Ella, Executive Chairman at Bharat Biotech, expressed excitement about the new opportunities to strengthen their shared vision, leverage the prowess of education and research capabilities to help build a healthier universe, and improve people’s lives by developing safer vaccine platforms.


Q.1 What is the main aim of the BBIL & Sydney University MoU?
a. To advance vaccine research initiatives
b. To develop new pharmaceutical drugs
c. To collaborate on agricultural research
d. To collaborate on space research

Can I help you?

ramandeep singh

Hey I am Ramandeep Singh. I am determined to help students preparing for RBI, SEBI, NABARD and IBPS exams. Do you want me to help you ?

Join my class here
    Follow me:
Close Menu
Close Menu